Glaucoma Medication and its Relationship with Depression
Brigita Deya Widiana1, Yulia Primitasari2*, and Citrawati Dyah Kencono Wungu3
Abstract
Glaucoma is a disease of progressive degeneration of the optic nerve which is the second leading cause of blindness worldwide, results in irreversible blindness. The only therapy proven to be effective is giving the medication for lowering intraocular pressure. This treatment is not curing glaucoma and must be done for lifelong. In glaucoma patients, it is found they experience depression and one of the factors is drug treatment itself. Therefore, this study was conducted to determine the relationship between the treatment given to glaucoma patients and the depression that appears in patients. The literature review was done in December 2022 by searching database from Google Scholar, PubMed, and ScienceDirect with key concepts “glaucoma”, “depression”, and “medication”. In conclusion, there is a link between glaucoma patients’ drug activities and the development of depression. Patients may experience depression due to a variety of interrelated factors, including their understanding of and adherence to their medicamentosa, its dosage, cost, and type of drug.
Keywords
glaucoma; depression; medication
Cite This Article
Widiana, B. D., Primitasari, Y., Wungu, C. D. K. (2023). Glaucoma Medication and its Relationship with Depression. International Journal of Scientific Advances (IJSCIA), Volume 4| Issue 1: Jan-Feb 2023, Pages 1-3, URL: https://www.ijscia.com/wp-content/uploads/2023/01/Volume4-Issue1-Jan-Feb-No.380-1-3.pdf
Volume 4 | Issue 1: Jan-Feb 2023
